Virginia university leads trial testing ARD-201, an oral drug to maintain weight loss after stopping GLP-1 treatments like ...

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight ...

This systematic review evaluates preclinical and clinical evidence on glucagon-like peptide-1 receptor agonists as potential ...

Research has shown that people who stop taking GLP-1 drugs, such as Ozempic and Wegovy, typically experience weight regain ...

Aurora IV and Wellness, a Cullman-based clinic, has been permanently closed following a state investigation that revealed the ...

Big moves are continuing in the weight loss landscape in the new year following breakthrough research of GLP-1 medications and other methods. Weight-loss experts spoke with Fox News Digital about ...

A 2026 Investigation Into the Mitochondria Theory, Real Results, Side Effects, and the Truth Behind the Reviews. NEW YORK, NY / ACCESS Newswire / January 9, 2026 / By early 2026, Mitolyn reviews are ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing research has found. This rate of weight regain is significantly faster than ...

If you’re ready to change your life but don’t know where to begin, Running for Weight Loss offers a clear, supportive path forward. Guided by experts, you’ll learn how metabolism works, understand ...

The blockbuster weight-loss drug semaglutide and its rivals promise to help reverse the global obesity epidemic – if only more of the people who would benefit from these treatments could afford them.

The best weight loss supplements for women may include magnesium, caffeine, green tea, protein, fiber, and vitamin B12. The FDA doesn’t closely regulate supplements, so they’re not guaranteed to be ...

Why I Might Skip JD Vance at the March for Life Rally Our Impossibly Small-Souled President Greenland: Digging a Deeper Hole Definition Deficiency at the Court Alright, the FDA under Robert F. Kennedy ...